Quality of life and the McPeek recovery index as a new outcome concept for sepsis trials tested in a pilot study of granulocyte colony-stimulating factor in patients with colorectal cancer

被引：0
|
作者：
Bauhofer, A
Stinner, B
Plaul, U
Torossian, A
Middeke, M
Celik, I
Koller, M
Lorenz, W
机构：
[1] Univ Marburg, Inst Theoret Surg, Marburg, Germany
[2] Univ Marburg, Dept Gen Surg, Marburg, Germany
[3] Univ Marburg, Dept Anaesthesia, Marburg, Germany
来源：
BRITISH JOURNAL OF SURGERY | 2001年 / 88卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1147 / 1147
页数：1
相关论文
共 50 条
  • [1] EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON QUALITY-OF-LIFE IN PATIENTS WITH SEVERE CHRONIC NEUTROPENIA
    JONES, E
    BOLYARD, A
    DALE, DC
    CLINICAL RESEARCH, 1993, 41 (01): : A65 - A65
  • [2] Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with fanconi anemia: A pilot study
    Rackoff, WR
    Orazi, A
    Robinson, CA
    Cooper, RJ
    Alter, BP
    Freedman, MH
    Harris, RE
    Williams, DA
    BLOOD, 1996, 88 (05) : 1588 - 1593
  • [3] New outcome concepts for sepsis trials tested in a pilot trial with G-CSF prophylaxis in patients with colorectal cancer
    Bauhofer, A
    Stinner, B
    Plaul, U
    Celik, I
    Middeke, M
    Torossian, A
    Lorenz, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R117 - R117
  • [4] New approach to evaluate survival benefit of granulocyte colony-stimulating factor in cancer patients receiving myelosuppressive chemotherapy
    Krendyukov, A.
    Yau, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report
    Tazawa, R
    Nakata, K
    Inoue, Y
    Nukiwa, T
    RESPIROLOGY, 2006, 11 : S61 - S64
  • [6] Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients
    Tolcher, AW
    Cowan, KH
    Noone, MH
    Denicoff, AM
    Kohler, DR
    Goldspiel, BR
    Barnes, CS
    McCabe, M
    Gossard, MR
    Zujewski, J
    OShaughnessy, JA
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 95 - 102
  • [7] PHASE-I STUDY OF TAXOL AND GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS WITH REFRACTORY OVARIAN-CANCER
    SAROSY, G
    KOHN, E
    STONE, DA
    ROTHENBERG, M
    JACOB, J
    ADAMO, DO
    OGNIBENE, FP
    CUNNION, RE
    REED, E
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) : 1165 - 1170
  • [8] A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor
    Philip, PA
    Rea, D
    Mitchell, K
    Carmichael, J
    Harris, AL
    Talbot, DC
    CLINICAL ONCOLOGY, 1999, 11 (02) : 84 - 89
  • [9] Semiallogeneic cancer vaccines formulated with granulocyte-macrophage colony-stimulating factor for patients with metastatic gastrointestinal adenocarcinomas: A pilot phase I study
    Newton, DA
    Acierno, PM
    Metts, MC
    Baron, PL
    Brescia, FJ
    Gattoni-Celli, S
    JOURNAL OF IMMUNOTHERAPY, 2001, 24 (01): : 19 - 26
  • [10] Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer
    Scheithauer, W
    Kornek, GV
    Raderer, M
    Valencak, J
    Weinländer, G
    Hejna, M
    Haider, K
    Kwasny, W
    Depisch, D
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 902 - 906
12345